These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37193623)

  • 1. Corrigendum to "Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB" [Int. Immunopharmacol. 101(Part B) (2021) 108290].
    Zhu Y; Ruan S; Shen H; Guan Q; Zhai L; Yang Y
    Int Immunopharmacol; 2023 Jun; 119():110302. PubMed ID: 37193623
    [No Abstract]   [Full Text] [Related]  

  • 2. Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB.
    Zhu Y; Ruan S; Shen H; Guan Q; Zhai L; Yang Y
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108290. PubMed ID: 34717194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways" [Int. Immunopharmacol. 55 (2018) 9-19].
    Li J; Bao L; Zha D; Zhang L; Gao P; Zhang J; Wu X
    Int Immunopharmacol; 2024 Jan; 126():111252. PubMed ID: 38040552
    [No Abstract]   [Full Text] [Related]  

  • 4. Retraction notice to "Corrigendum to "MLL1 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by activating the TRIF/NF-κB signaling pathway via H3K4me3 enrichment in the TLR4 promoter region"" [Int. Immunopharmacol. 82 (2020) 106220] [Int. Immunopharmacol. 92 (2021) 107321].
    Zhang Y; Ji T; Ma S; Wu W
    Int Immunopharmacol; 2023 Apr; 117():109865. PubMed ID: 36822094
    [No Abstract]   [Full Text] [Related]  

  • 5. Oridonin stabilizes retinoic acid receptor alpha through ROS-activated NF-κB signaling.
    Cao Y; Wei W; Zhang N; Yu Q; Xu WB; Yu WJ; Chen GQ; Wu YL; Yan H
    BMC Cancer; 2015 Apr; 15():248. PubMed ID: 25886043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "MicroRNA-208-5p regulates myocardial injury of sepsis mice via targeting SOCS2-mediated NF-κB/HIF-1α pathway" [Int. Immunopharmacol. 81 (2020) 106204].
    Ouyang H; Tan Y; Li Q; Xia F; Xiao X; Zheng S; Lu J; Zhong J; Hu Y
    Int Immunopharmacol; 2022 Mar; 104():108355. PubMed ID: 35058156
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis.
    Nishio T; Taura K; Iwaisako K; Koyama Y; Tanabe K; Yamamoto G; Okuda Y; Ikeno Y; Yoshino K; Kasai Y; Okuno M; Seo S; Sakurai T; Asagiri M; Hatano E; Uemoto S
    J Gastroenterol; 2017 Aug; 52(8):965-976. PubMed ID: 28044208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to "4-Hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice" [Int. Immunopharmacol. 83 (2020) 106445].
    Wang H; Wei X; Wei X; Sun X; Huang X; Liang Y; Xu W; Zhu X; Lin X; Lin J
    Int Immunopharmacol; 2020 Sep; 86():106722. PubMed ID: 32593975
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Gypsophila elegans isoorientin-2″-O-α-L-arabinopyranosyl ameliorates porcine serum-induced immune liver fibrosis by inhibiting NF-κB signaling pathway and suppressing HSC activation" [Int. Immunopharmacol. 54 (2018) 60-67].
    Bai F; Huang Q; Wei J; Lv S; Chen Y; Liang C; Wei L; Lu Z; Lin X
    Int Immunopharmacol; 2023 Sep; 122():110697. PubMed ID: 37500383
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to 'Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways'. [Int. Immunopharmacol. 75 (2019) 105739].
    Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
    Int Immunopharmacol; 2020 Jul; 84():105962. PubMed ID: 31948857
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Gallic acid improved inflammation via NF-κB pathway in TNBS-induced ulcerative colitis" [Int. Immunopharmacol. 67 (2019) 129-137].
    Zhu L; Gu P; Shen H
    Int Immunopharmacol; 2021 Oct; 99():107815. PubMed ID: 34130920
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Sodium houttuyfonate enhances the intestinal barrier and attenuates inflammation induced by Salmonella typhimurium through the NF-κB pathway in mice" [Int. Immunopharmacol. 89 (2020) 107058].
    Zhang L; Lv H; Li Y; Dong N; Bi C; Shan A; Wu Z; Shi B
    Int Immunopharmacol; 2021 Mar; 92():107351. PubMed ID: 33444920
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to 'Protective effect of kobophenol A on nitric oxide-induced cell apoptosis in human osteoblast-like MG-63 cells: Involvement of JNK, NF-κB and AP-1 pathways' [Int. Immunopharmacol. 11 (2011) 1251-1259].
    Lee SR; Kwak JH; Park DS; Pyo S
    Int Immunopharmacol; 2019 Jan; 66():388. PubMed ID: 30473316
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Melatonin inhibits the formation of chemically induced experimental encapsulating peritoneal sclerosis through modulation of T cell differentiation by suppressing of NF-κB activation in dendritic cells" [Int. Immunopharmacol. 126 (2024) 111300].
    Huang SH; Hong ZJ; Chen MF; Tsai MW; Chen SJ; Cheng CP; Sytwu HK; Lin GJ
    Int Immunopharmacol; 2024 Apr; 131():111683. PubMed ID: 38368242
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Alpha-Mangostin suppresses interleukin-1β-induced apoptosis in rat chondrocytes by inhibiting the NF-κB signaling pathway and delays the progression of osteoarthritis in a rat model" [Int. Immunopharmacol. 52 (2017) 156-162].
    Pan T; Chen R; Wu D; Cai N; Shi X; Li B; Pan J
    Int Immunopharmacol; 2018 Dec; 65():559-560. PubMed ID: 30412853
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Baicalin suppresses IL-1β-induced expression of inflammatory cytokines via blocking NF-κB in human osteoarthritis chondrocytes and shows protective effect in mice osteoarthritis models" [Int. Immunopharmacol. 52 (2017) 218-226].
    Chen C; Zhang C; Cai L; Xie H; Hu W; Wang T; Lu D; Chen H
    Int Immunopharmacol; 2021 Jun; 95():107546. PubMed ID: 33735716
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Rapamycin regulates osteogenic differentiation through Parkin-mediated mitophagy in rheumatoid arthritis" [Int. Immunopharmacol. 113(Part B) (2022) 109407].
    Chen Q; Fan K; Song G; Wang X; Zhang J; Chen H; Qin X; Lu Y; Qi W
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110941. PubMed ID: 37718175
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Antidepressant-like effects of helicid on a chronic unpredictable mild stress-induced depression rat model: Inhibiting the IKK/IκBα/NF-κB pathway through NCALD to reduce inflammation" [Int. Immunopharmacol. 93 (2021) 107165].
    Zhang YX; Zhang XT; Li HJ; Zhou TF; Zhou AC; Zhong ZL; Liu YH; Yuan LL; Zhu HY; Luan D; Tong JC
    Int Immunopharmacol; 2023 Aug; 121():110611. PubMed ID: 37468398
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
    Dong X; Liu F; Li M
    Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
    Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.